new_0222_0170|CCCC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0170|CCCC|1|C4 Therapeutics Inc Total Current Assets (Quarterly) (USD)|C4 Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|C4 Therapeutics Inc Inventories (Quarterly) (USD)|C4 Therapeutics Inc Net PP&E (Quarterly) (USD)|C4 Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|C4 Therapeutics Inc Total Liabilities (Quarterly) (USD)|C4 Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|C4 Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|C4 Therapeutics Inc Total Deposits (Quarterly) (USD)|C4 Therapeutics Inc Book Value (Quarterly) (USD)|C4 Therapeutics Inc Retained Earnings (Quarterly) (USD)|C4 Therapeutics Inc Treasury Stock (Quarterly) (USD)|C4 Therapeutics Inc EV to Revenues|C4 Therapeutics Inc EV to Earnings|C4 Therapeutics Inc EV to Free Cash Flow|C4 Therapeutics Inc EV to Assets (Quarterly)|C4 Therapeutics Inc PS Ratio|C4 Therapeutics Inc PE Ratio|C4 Therapeutics Inc Price to Book Value|C4 Therapeutics Inc PEG Ratio|C4 Therapeutics Inc Debt to Equity Ratio|C4 Therapeutics Inc Dividend Yield|C4 Therapeutics Inc Shareholder Yield (TTM)|C4 Therapeutics Inc Percent of Shares Outstanding Short|C4 Therapeutics Inc Total Receivables (Quarterly) (USD)|C4 Therapeutics Inc Total Payables (Quarterly) (USD)|C4 Therapeutics Inc Total Capital Stock (Quarterly) (USD)|C4 Therapeutics Inc Return on Invested Capital|C4 Therapeutics Inc Quality Ratio Score|C4 Therapeutics Inc Momentum Score|C4 Therapeutics Inc Beta (1Y)|C4 Therapeutics Inc Sustainable Growth Rate (TTM)|C4 Therapeutics Inc Institutional Investor Ownership Percentage|C4 Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|C4 Therapeutics Inc Total Employees (Annual)|C4 Therapeutics Inc EPS Diluted (Quarterly) (USD)|C4 Therapeutics Inc Shares Outstanding|C4 Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|C4 Therapeutics Inc Ordinary Shares Number (Quarterly)|C4 Therapeutics Inc Payout Ratio|C4 Therapeutics Inc Quick Ratio (Quarterly)|C4 Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|C4 Therapeutics Inc Stock Buybacks (Quarterly) (USD)|C4 Therapeutics Inc Effective Tax Rate (TTM)|C4 Therapeutics Inc Return on Equity|C4 Therapeutics Inc Net Income (TTM) (USD)|C4 Therapeutics Inc Revenue (TTM) (USD)|C4 Therapeutics Inc Dividend Per Share (Quarterly) (USD)|C4 Therapeutics Inc Revenue (Quarterly) (USD)|C4 Therapeutics Inc Gross Profit (Quarterly) (USD)|C4 Therapeutics Inc SG&A Expense (Quarterly) (USD)|C4 Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|C4 Therapeutics Inc Net Income (Quarterly) (USD)|C4 Therapeutics Inc Net Interest Income (Quarterly) (USD)|C4 Therapeutics Inc Price (USD)|C4 Therapeutics Inc Total Return Price (USD)|C4 Therapeutics Inc Enterprise Value (USD)|C4 Therapeutics Inc 30-Day Average Daily Volume|C4 Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0170|CCCC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0170|CCCC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0170|CCCC|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||1.44956772334|91|1.44912280702|91|1.44827586207||1.44755244755||91.2857142857|1.44956772334|91|15.2580645161|106.5|106.5|106.5|91||31|30.6666666667|91|30.5|91.375|184|91.375|26.6|91.4|106.5|91.4|91.2857142857|91.375|91.4|91.4|91|91.4|91.4||91.375||91.375|91.375|91.375|91.375|1.44827586207|1.44827586207|1.44956772334|1.45283018868|1.43157894737||
new_0222_0170|CCCC|6|6|6||6||6|6|6||6|6||347|3|285|3|348||286||7|347|3|31|6|6|6|3||2|3|3|14|8|1|8|15|5|6|5|7|8|5|5|3|5|5||8||8|8|8|8|348|348|347|318|95||
new_0222_0170|CCCC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0170|CCCC|201909||||||||||||||||||||||||||||||||||17.233||-0.7135||||||-0.5857|||||||5.364||2.417|-9.444|-10.094|0.558|||||||
new_0222_0170|CCCC|201912|96.767|90.549||18.916||230.223|33.641|196.582||-111.963|-117.488||||||||||||||4.623|5.385||||||||17.233||-0.694|||40.7692||2.829|-0.5816|||||||8.209||2.691|-10.119|-10.023|0.703|||||||
new_0222_0170|CCCC|202003||||||||||||||||||||||||||||||||||17.233||-0.8137||||||-0.6912|||||||6.816||2.842|-12.079|-11.912|0.259|||||||
new_0222_0170|CCCC|202006|227.918|216.094||17.572||124.286|35.114|89.172||123.781|-140.193||||||||||0.0782||||8.546|5.861|0.004|||||||40.7692|88|-0.3361||-0.124|43.0596||6.3974|-0.2647|-140.902|-0.514||-42.822|30.059||9.67||2.769|-10.961|-10.793|-0.102|||||||
new_0222_0170|CCCC|202009|208.924|199.413||17.123||385.051|40.009|345.042||-155.924|-162.028||26.3819||||21.6576||||-0.0633|||1.0959|4.141|5.264|0.001||||||6.2847|40.7692||-0.6634|40.7692|-0.086|41.5452||5.0877|-0.587|-4.413|1.0841||-54.563|33.142||8.447||2.861|-22.002|-21.835|-0.512|24.75|24.75|874.3477|705912.9||34.2|
new_0222_0170|CCCC|202012|381.009|371.689||16.552||119.347|43.852|75.495||280.791|-183.823||32.081|-16.0538|-15.684|2.6614|35.3883||5.0805||0.0358||-0.1409|3.9688|4.484|5.683|0.004|-159.5665||||-194.1252|68.8302|43.0596|99|-0.2655|43.0596|0.016|43.0596||8.5782|-0.207|-195.09|0.9349|-194.1252|-66.335|33.195||8.262||6.732|-21.919|-21.795|-0.481|33.13|33.13|1064.9275|452109.9||36.12|42.92
new_0222_0170|CCCC|202103|322.011|313.479||16.924||110.302|37.653|72.649||263.705|-204.794||38.2001|-17.1281|-16.9017|3.4528|45.8704||6.0469||0.0388||-21.4757|8.5123|3.656|3.742|0.004|-54.6148||||-94.1507|95.362|43.085||-0.49|43.109||43.109||8.4226|-0.49||0.6051|-94.1507|-75.394|33.805||7.426||7.409|-20.971|-20.971|-0.462|36.99|36.99|1291.3539|291389.7667||33.1|36.95
new_0222_0170|CCCC|202106|477.561|465.911||16.235||111.994|44.166|67.828||416.427|-227.374||40.5473|-15.7741|-17.0477|2.6025|47.6317||4.3962||0.025||-20.2938|5.7757|6.213|4.469|0.005|-44.5245||||-46.9331||43.8554||-0.51|48.3801||48.3801||10.6898|-0.51|-169.934|0.3327|-46.9331|-87.181|33.916||9.781||8.611|-22.58|-22.58|-0.464|37.84|37.84|1375.201|643618.2333||43.14|40.13
new_0222_0170|CCCC|202109|412.294|402.071||15.572||109.131|48.687|60.444||398.78|-252.057||52.391|-19.7677|-21.0996|3.5039|58.6929||5.4445||0.0266||-16.7993|5.4794|4.845|3.745|0.005|-35.87||8|0.4981|-37.3943|98.4933|48.4905||-0.51|48.5934||48.5934||8.3578|-0.51|0.469|0.1375|-37.3943|-90.029|33.969||8.5||8.452|-24.683|-24.683|-0.429|44.68|44.68|1779.6701|352022.7667|77.0426|44.42|37.12
new_0222_0170|CCCC|202112|||||||||||||34.5686||-13.922||42.2988||3.9263|||||6.5337||||||5|-1.4769||98.5424||||||||||||||||||||||32.2|32.2|1174.2613|369037.4333|-2.8071|24.43|21.09